- Price
- $21.89
- Day
- +1.06%
- Mkt Cap
- $4.09B
- 52W Range
- $17.15 – $76.51
- Volume
- 2.07M
- Beta
- 1.29
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
California Public Employees Retirement System lifted its stake in shares of Doximity, Inc. (NYSE: DOCS) by 19.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 285,254 shares of the company's stock after acquiring an additional 46,898 shares during the
Read full article
Doximity (DOCS) concluded the recent trading session at $20.99, signifying a +2.79% move from its prior day's close.
Read full article
Doximity (NYSE: DOCS - Get Free Report) and OBOOK (NASDAQ: OWLS - Get Free Report) are both services companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Analyst Recommendations This is a summary of current ratings for
Read full article
DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.
Read full article
Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.
Read full article
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before.
Read full article
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the most comprehensive independent evaluations of clinical AI safety to date. The study, conducted by ARISE, a clinical AI research team led by physicians from Stanford and.
Read full article